Benefits
Skin hydration and barrier (indexed RCT)
In a randomized, placebo-controlled oral trial, konjac glucosylceramides reduced graded skin dryness, redness and itching versus placebo — a published, PubMed-indexed study, though it was small, single-blind and run by the manufacturer.
Reduced water loss / smoother skin
Oral glucosylceramides are consistently linked to lower transepidermal water loss and improved skin smoothness in the broader literature.
Plant-based ceramide source
Konjac provides a vegan, food-derived glucosylceramide alternative to wheat- or rice-derived ceramides.
Mechanism of action
Ceramide replenishment of the skin barrier
Dietary glucosylceramides are thought to support the skin's own ceramide synthesis, strengthening the lipid barrier that holds in moisture.
Reduced transepidermal water loss
A stronger ceramide barrier lowers water loss through the skin, improving hydration and suppleness.
Clinical trials
Monocentric, single-blind, placebo-controlled, randomized; oral 100 mg/day (~5 mg glucosylceramides) for 6 weeks (BMC Complementary Medicine and Therapies, 2020).
51 subjects (40 completed)
Oral konjac glucosylceramides reduced graded skin dryness, redness and itching versus placebo. A small, single-blind, manufacturer-sponsored but genuinely published, indexed trial of the branded ingredient.
Randomized trials of oral plant glucosylceramides for skin.
Adults seeking skin hydration
Oral glucosylceramides improve skin hydration and reduce water loss, supporting the mechanism behind Skin-Cera.